Cytek Biosciences Inc (CTKB)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 200,453 | 193,015 | 164,036 | 127,950 | 92,839 |
| Property, plant and equipment | US$ in thousands | — | — | 13,682 | 5,851 | 2,140 |
| Fixed asset turnover | — | — | 11.99 | 21.87 | 43.38 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $200,453K ÷ $—K
= —
The fixed asset turnover ratio measures a company's efficiency in generating revenue from its investment in fixed assets. Looking at the data provided for Cytek Biosciences Inc, we observe a significant decrease in the fixed asset turnover ratio over the years.
In December 31, 2020, the fixed asset turnover was 43.38, indicating that Cytek Biosciences was generating $43.38 in revenue for every dollar invested in fixed assets. However, this ratio declined to 21.87 in December 31, 2021 and further dropped to 11.99 in December 31, 2022.
The absence of data for December 31, 2023, and December 31, 2024, makes it difficult to analyze the trend further. Nonetheless, the decreasing trend in fixed asset turnover raises concerns about Cytek Biosciences Inc's ability to efficiently utilize its fixed assets to generate revenue. It may be necessary for the company to review its asset management strategies to improve operational efficiency and productivity.
Peer comparison
Dec 31, 2024